AnLong Bio

At Anlong Bio, patients are our priority. Since launching, our goal has been to deliver transformative gene therapy medicines to patients faster and at low cost, in China and globally. We aim to provide unmatched access to treatments for patients through our extensive resources, our experienced leadership and advisory teams, and our trusted network of partners

Lentivirus,aav,gene therapy,rnai,scalable manufacturing,crispr,gene editing,ocular gene therapy,wamd,damd,he,hemb/a,mrna,global expansion,business development,clinical development,and china go to market

Anlong bio operates in the Biotechnology research industry.

Anlong bio's revenue is 11m - 100m

Anlong bio has 11 - 50 employees.